5-Amino-1MQ Reference Guide: NNMT Inhibition and Metabolic Research

5-amino-1MQ (5-amino-1-methylquinolinium iodide) is a first-in-class small molecule inhibitor of nicotinamide N-methyltransferase (NNMT). It sits in a different research category from most compounds shelved as “peptide research” — it is a small heterocyclic molecule, not a peptide — but it is studied for adjacent metabolic biology questions and frequently appears alongside NAD+ and sirtuin research.

Its mechanism is narrow and clean: it inhibits NNMT, the enzyme that consumes nicotinamide and S-adenosylmethionine (SAM) to produce 1-methylnicotinamide (MNA). That makes 5-amino -1MQ a tool for asking what happens when this single methyl transferase is shut off in models where it is overactive.

At a glance

NNMT biology in one paragraph

Nicotinamide N-methyltransferase (NNMT) is a cytosolic enzyme that uses SAM as a methyl donor to methylate nicotinamide, producing 1-methylnicotinamide (MNA) and S-adenosylhomocysteine (SAH). NNMT is expressed across many tissues but is enriched in white adipose tissue and liver. In published research, elevated NNMT activity is associated with reduced NAD+ salvage capacity (because nicotinamide is diverted away from the NAD+ salvage pathway), reduced cellular SAM pools (because SAM is consumed as methyl donor), and changes in adipocyte energy expenditure.

What 5-amino-1MQ does

5-amino-1MQ binds and inhibits NNMT directly. In cellular research models, inhibition produces three measurable downstream changes:

• Elevated cellular nicotinamide. Without NNMT-mediated consumption, nicotinamide is preserved for re-entry into the NAD+ salvage pathway via NAMPT.
• Elevated cellular SAM. The methyl donor pool is preserved when not drained by NNMT, with downstream effects on broader methylation balance.
• Reduced MNA output. 1-methylnicotinamide drops, which is the most direct biochemical readout of NNMT inhibition and is commonly used to confirm target engagement in research models.

What research models use it

• Adipocyte differentiation and biology: White vs brown adipocyte models where NNMT is overexpressed; energy expenditure and lipid storage endpoints.
• NAD+ salvage pathway research: Pairing with NAMPT activators or NAD+ precursors (NMN, NR) to study how shutting off nicotinamide consumption changes NAD+ dynamics.
• Sirtuin pathway research: Because sirtuins depend on NAD+, NNMT inhibition is studied as an upstream modulator of SIRT1 / SIRT3 activity in metabolic models.
• Methylation balance studies: Hepatic methylation, choline-methionine cycle, and broader one-carbon metabolism research where SAM availability is a rate-limiting step.
• Age-related metabolic decline: Aging models where NNMT expression rises and NAD+ availability falls in parallel.

How 5-amino-1MQ fits with NAD+ research tools

Research on the NAD+ axis usually divides into three categories of intervention:

• Precursor supplementation (NMN, NR, nicotinamide riboside): feeding the salvage pathway from upstream.
• Direct NAD+ (where applicable, e.g., NAD+ itself for in vitro work): bypassing the salvage pathway.
• Salvage-pathway protection (NNMT inhibition via 5-amino-1MQ): preventing nicotinamide from being lost to methylation.

The three approaches answer different mechanistic questions and are often compared in parallel arms within the same study. For NAD+ axis context, see the NAD+ Reference Guide.

Lab handling

5-amino-1MQ is supplied as a lyophilized solid (typically the iodide salt). It is water-soluble and reconstitutes cleanly for in vitro work. Lyophilized stability at −20°C is typical; once in solution, refrigerated stability ranges from days to weeks depending on storage conditions and is shorter than for the lyophilized form. Standard practice — gentle swirling, aliquoting, and limited freeze-thaw — applies.

Because 5-amino-1MQ is a small molecule rather than a peptide, the cold-chain and reconstitution sensitivities common to long-chain peptides are less critical, but the same aliquoting discipline still helps maintain a clean working stock.

When to choose 5-amino-1MQ in a research design

• Investigating NNMT specifically: 5-amino-1MQ is the cleanest small-molecule inhibitor available for in vitro and animal research.
• NAD+ salvage pathway research: as the salvage-protection arm alongside precursor supplementation.
• Adipocyte metabolic biology: where white adipose NNMT is hypothesized as the driver of energy expenditure differences.
• One-carbon / methylation studies: where SAM availability is the question.

For Research Use Only. Information presented for laboratory and research applications. Not medical advice and not a substitute for qualified scientific judgment.